Charles R. Kummeth - 04 Jan 2023 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Chief Executive Officer, Director
Signature
/s/ Brenda S. Furlow, Attorney-in-Fact
Issuer symbol
TECH
Transactions as of
04 Jan 2023
Net transactions value
-$10,733,834
Form type
4
Filing time
06 Jan 2023, 15:37:56 UTC
Previous filing
17 Aug 2022
Next filing
22 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $10,856,251 +407,364 +42% $26.65 1,368,976 04 Jan 2023 Direct F1
transaction TECH Common Stock Tax liability $21,590,084 -255,837 -19% $84.39 1,113,139 04 Jan 2023 Direct
holding TECH Common Stock 400 04 Jan 2023 By Step-Son
holding TECH Common Stock 400 04 Jan 2023 By Step-Daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Options Exercise $0 -407,364 -40% $0.000000 616,676 04 Jan 2023 Common Stock 407,364 $26.65 Direct F2
holding TECH Stock Options (Right to Buy) 779,084 04 Jan 2023 Common Stock 779,084 $31.26 Direct F2
holding TECH Stock Options (Right to Buy) 361,336 04 Jan 2023 Common Stock 361,336 $44.33 Direct F2
holding TECH Stock Options (Right to Buy) 240,888 04 Jan 2023 Common Stock 240,888 $44.33 Direct F2
holding TECH Stock Options (Right to Buy) 342,900 04 Jan 2023 Common Stock 342,900 $47.60 Direct F2
holding TECH Restricted Stock Units 52,900 04 Jan 2023 Common Stock 52,900 Direct F3, F4
holding TECH Stock Options (Right to Buy) 1,200,000 04 Jan 2023 Common Stock 1,200,000 $94.52 Direct F5
holding TECH Stock Options (Right to Buy) 228,600 04 Jan 2023 Common Stock 228,600 $47.60 Direct F6
holding TECH Restricted Stock Units 51,516 04 Jan 2023 Common Stock 51,516 Direct F3, F7
holding TECH Stock Options (Right to Buy) 299,768 04 Jan 2023 Common Stock 299,768 $66.97 Direct F7
holding TECH Stock Options (Right to Buy) 153,180 04 Jan 2023 Common Stock 153,180 $66.97 Direct F8
holding TECH Stock Options (Right to Buy) 66,600 04 Jan 2023 Common Stock 66,600 $66.97 Direct F9
holding TECH Stock Options (Right to Buy) 66,600 04 Jan 2023 Common Stock 66,600 $66.97 Direct F10
holding TECH Restricted Stock Units 32,064 04 Jan 2023 Common Stock 32,064 Direct F3, F11
holding TECH Stock Options (Right to Buy) 125,260 04 Jan 2023 Common Stock 125,260 $120.46 Direct F11
holding TECH Stock Options (Right to Buy) 83,504 04 Jan 2023 Common Stock 83,504 $120.46 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024.
F2 Fully exercisable.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F4 17,632 shares vest on each of 8/15/2023 and 8/15/2025, and 17,636 shares vest on 8/15/2024.
F5 600,000 options vest in full or in part on 7/1/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator), and 600,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 Options to purchase 57,152 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 57,148 shares vest on each of 8/7/2022 and 8/7/2023.
F7 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 38,292 shares vest on 8/5/21 and options to purchase 38,296 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
F9 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F10 Options to purchase 22,200 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
F11 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F12 Options to purchase 20,876 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.

Remarks:

On November 28, 2022, the Company completed a four-for-one stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to November 28, 2022 have been adjusted to reflect the four-for-one stock split.